Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...

Kura Oncology shares rise this week after the FDA accepts its NDA for ziftomenib, a potential first-in-class treatment for NPM1-mutant AML.

A team of researchers at the University of Minnesota recently completed a human trial for a novel gene-editing treatment, ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...

Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...

A recent trial reveals that durvalumab enhances event-free survival in patients with resectable gastric and gastroesophageal junction adenocarcinoma.

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies ... used for previously untreated upper gastrointestinal (GI) cancers. Preliminary data ...

We have previously reported an association between increased sedation use and lower rates of post endoscopy upper GI cancer. We have analysed sedation practices for diagnostic upper GI endoscopy in ...